Nov 29, 2017

Democratic group will invest $4 million to train 50k candidates in 2018

NDTC founder and CEO Kelly Dietrich during a training session. Photo courtesy of NDTC

The National Democratic Training Committee (NDTC), which makes a free online candidate training program, plans to spend $4 million in 2018 in the hopes of getting 50,000 Dems to use their services to run for office.

Why it matters: The digital approach could help the party attract younger candidates — ultimately helping address the Democrats' old-people problem.

Democratic Rep. Cheri Bustos is supporting NDTC in their efforts to assist Dems in claiming some of the 518,000 elected official positions next year, all in the hopes of helping the party regain some of the seats they've lost to Republicans at every level over the last 10 years.

By the numbers:

  • Some of the $4 million will go toward creating more interactive training sessions for the group's free online training program, but an estimated $600,000 of that will be used for NDTC in-person training sessions inspired by Rep. Bustos' "Build the Bench" program.
  • The seven states the group is targeting in the first few weeks of 2018 include Indiana, Massachusetts, Texas, Michigan, Idaho, Missouri and Wyoming.
  • More than 10,000 Dems have signed up for NDTC training since the group started in 2016.

What they're saying: "Democrats clearly have momentum on their side," said Kelly Dietrich, founder and CEO of NDTC."While we can ride the momentum, we can't rely on it. We need to recruit candidates for every race up and down the ballot, but just as importantly we must stand with and invest in those who we recruit."

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3 a.m. ET: 665,164 — Total deaths: 30,852 — Total recoveries: 140,225.
  2. U.S.: Leads the world in cases. Total confirmed cases as of 3 a.m. ET: 124,665 — Total deaths: 2,191 — Total recoveries: 1,095.
  3. Federal government latest: President Trump announces new travel advisories for New York, New Jersey and Connecticut, but rules out quarantine enforcement. Per the CDC, residents of those states must now "refrain from non-essential domestic travel for 14 days," with the exception of critical infrastructure industry workers.
  4. State updates: Alaska is latest state to issue a stay-at-home order — New York is trying to nearly triple its hospital capacity in less than a month and has moved its presidential primary to June 23. Some Midwestern swing voters who backed Trump's handling of the virus less than two weeks ago are balking at his call for the U.S. to be "opened up" by Easter.
  5. World updates: In Spain, over 1,400 people were confirmed dead between Thursday to Saturday.
  6. 🚀 Space updates: OneWeb filed for bankruptcy amid the novel coronavirus pandemic.
  7. Hollywood: Tom Hanks and Rita Wilson have returned to U.S. after being treated for coronavirus.
  8. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk
  9. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Coronavirus updates: Global death toll tops 30,000

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens and confirmed plus presumptive cases from the CDC

The novel coronavirus has now killed more than 30,000 people around the world — with Italy reporting over 10,000 deaths, per Johns Hopkins data.

The big picture: The number of deaths from COVID-19 in the U.S. surpassed 2,000 on Saturday. The United States leads the world in confirmed coronavirus infections — more than 124,000 by early Sunday. The number of those recovered from the virus in the U.S. passed the 1,000-mark on Saturday evening.

Go deeperArrowUpdated 3 hours ago - Health

Gilead expands access to experimental coronavirus drug in emergency cases

Photo: Olivier Douliery/AFP via Getty Images

Gilead Sciences CEO Daniel O’Day said in an open letter Saturday the company is expanding access to its experimental anti-coronavirus drug remdesivir to include severely ill COVID-19 patients.

The big pig picture: President Trump has called the antiviral drug "promising," but the results of six clinical trials on this investigational medicine are still being conducted, so its effectiveness the treatment of the novel coronavirus has yet to be proved. The World Health Organization is involved in the tests.

Go deeperArrow3 hours ago - Health